Cargando…
Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains
OBJECTIVE: Escherichia coli ST131 is a pandemic clone associated with multidrug resistance, starting with beta-lactamase production and fluoroquinolone resistance in the first place, leading to significant systemic infections. Clones that develop due to the frequency of antimicrobial resistance and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229391/ https://www.ncbi.nlm.nih.gov/pubmed/37256442 http://dx.doi.org/10.1007/s11033-023-08532-z |
_version_ | 1785051239334019072 |
---|---|
author | Celebi, Demet Aydın, Elif Rakici, Erva Baser, Sumeyye Celebi, Ozgur Taghizadehghalehjoughi, Ali |
author_facet | Celebi, Demet Aydın, Elif Rakici, Erva Baser, Sumeyye Celebi, Ozgur Taghizadehghalehjoughi, Ali |
author_sort | Celebi, Demet |
collection | PubMed |
description | OBJECTIVE: Escherichia coli ST131 is a pandemic clone associated with multidrug resistance, starting with beta-lactamase production and fluoroquinolone resistance in the first place, leading to significant systemic infections. Clones that develop due to the frequency of antimicrobial resistance and the rate of spread in our country are important issues that need to be investigated. This study aims to investigate the incidence of ST131which is a “high-risk pandemic clone E. coli” in ESBL-producing and non-ESBL-producing strains, as well as their biofilm-forming abilities and antibiotic resistance rates. MATERIALS AND METHODS: A total of 86 E. coli isolates were used in the study. Bacterial identifications were performed by conventional and automated methods. The double disc synergy method was used to demonstrate the presence of ESBL. Molecular studies in all E. coli strains were performed by real-time PCR method. Findings: 86 strains were studied, of which 83.72% were urine, 6.98% were wound, 4.65% were blood, and 2.33% were tracheal aspirate and sputum. 79.07% of these strains were ESBL-positive. 58.1% of the strains were female, whereas 41.9% were male patients, and the average age was 46.2. Out of 86 strains, 38.72% were ST131 positive, the H30 subclone was detected in 27.27% of them, and the H30-Rx subclone was detected in all of the H30 subclone positive strains. The presence of the ESBL resistance gene was detected at the rate of TEM 41.86%, SHV 37.21%, CTX-M 36.04%, and OXA 4.65%. Most commonly SHV gene (54.54%) was seen in ST131 clone-positive samples. Finally, while it was found that 48.83% of the strains formed biofilm by any method, biofilm formation was detected in 69.7% of the samples that were positive for the ST131 clone. RESULT: Our study can reveal the dramatic prevalence of the ESBL-producing E. coli strains along with the high-risk ST131 clone, the dominance of the H30Rx subclone of this risky clone, as well as the importance of the influence of resistance mechanisms along with resistance and biofilm. |
format | Online Article Text |
id | pubmed-10229391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-102293912023-06-01 Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains Celebi, Demet Aydın, Elif Rakici, Erva Baser, Sumeyye Celebi, Ozgur Taghizadehghalehjoughi, Ali Mol Biol Rep Original Article OBJECTIVE: Escherichia coli ST131 is a pandemic clone associated with multidrug resistance, starting with beta-lactamase production and fluoroquinolone resistance in the first place, leading to significant systemic infections. Clones that develop due to the frequency of antimicrobial resistance and the rate of spread in our country are important issues that need to be investigated. This study aims to investigate the incidence of ST131which is a “high-risk pandemic clone E. coli” in ESBL-producing and non-ESBL-producing strains, as well as their biofilm-forming abilities and antibiotic resistance rates. MATERIALS AND METHODS: A total of 86 E. coli isolates were used in the study. Bacterial identifications were performed by conventional and automated methods. The double disc synergy method was used to demonstrate the presence of ESBL. Molecular studies in all E. coli strains were performed by real-time PCR method. Findings: 86 strains were studied, of which 83.72% were urine, 6.98% were wound, 4.65% were blood, and 2.33% were tracheal aspirate and sputum. 79.07% of these strains were ESBL-positive. 58.1% of the strains were female, whereas 41.9% were male patients, and the average age was 46.2. Out of 86 strains, 38.72% were ST131 positive, the H30 subclone was detected in 27.27% of them, and the H30-Rx subclone was detected in all of the H30 subclone positive strains. The presence of the ESBL resistance gene was detected at the rate of TEM 41.86%, SHV 37.21%, CTX-M 36.04%, and OXA 4.65%. Most commonly SHV gene (54.54%) was seen in ST131 clone-positive samples. Finally, while it was found that 48.83% of the strains formed biofilm by any method, biofilm formation was detected in 69.7% of the samples that were positive for the ST131 clone. RESULT: Our study can reveal the dramatic prevalence of the ESBL-producing E. coli strains along with the high-risk ST131 clone, the dominance of the H30Rx subclone of this risky clone, as well as the importance of the influence of resistance mechanisms along with resistance and biofilm. Springer Netherlands 2023-05-31 /pmc/articles/PMC10229391/ /pubmed/37256442 http://dx.doi.org/10.1007/s11033-023-08532-z Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Celebi, Demet Aydın, Elif Rakici, Erva Baser, Sumeyye Celebi, Ozgur Taghizadehghalehjoughi, Ali Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains |
title | Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains |
title_full | Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains |
title_fullStr | Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains |
title_full_unstemmed | Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains |
title_short | Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains |
title_sort | evaluation of presence of clone st131 and biofilm formation in esbl producing and non-producing escherichia coli strains |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229391/ https://www.ncbi.nlm.nih.gov/pubmed/37256442 http://dx.doi.org/10.1007/s11033-023-08532-z |
work_keys_str_mv | AT celebidemet evaluationofpresenceofclonest131andbiofilmformationinesblproducingandnonproducingescherichiacolistrains AT aydınelif evaluationofpresenceofclonest131andbiofilmformationinesblproducingandnonproducingescherichiacolistrains AT rakicierva evaluationofpresenceofclonest131andbiofilmformationinesblproducingandnonproducingescherichiacolistrains AT basersumeyye evaluationofpresenceofclonest131andbiofilmformationinesblproducingandnonproducingescherichiacolistrains AT celebiozgur evaluationofpresenceofclonest131andbiofilmformationinesblproducingandnonproducingescherichiacolistrains AT taghizadehghalehjoughiali evaluationofpresenceofclonest131andbiofilmformationinesblproducingandnonproducingescherichiacolistrains |